Physician profile

Taryn Haney

Internal Medicine · Tulsa, OK

NPI 1508447533

$5,130.73

in general payments reported to CMS, 2019-2025

33 companies · $3,275 in 2025

The $3,275 reported for 2025 was more than what 96% of Internal Medicine providers received nationally (typical 2025 total: $156).

See the full distribution for Internal Medicine

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$4,801.10

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Gilead Sciences, INC. $868.57 2023-2025 Biktarvy, Yeztugo
Novo Nordisk INC $721.19 2024-2025 Wegovy, Ozempic, Rybelsus
Astrazeneca Pharmaceuticals LP $500.75 2022-2025 Airsupra, Farxiga
Viiv Healthcare Company $435.33 2022-2025 Rukobia, Cabenuva, Dovato
Bayer Healthcare Pharmaceuticals INC. $304.21 2024-2025
Lilly USA, LLC $239.10 2024-2025 Zepbound, Mounjaro, Jardiance
Boehringer Ingelheim Pharmaceuticals, INC. $220.13 2023-2025 Jardiance
Glaxosmithkline, LLC. $215.29 2024-2025 Trelegy Ellipta, Arexvy
Pfizer INC. $202.50 2024-2025
Amgen INC. $166.06 2024-2025 Evenity, Otezla, Repatha
Boston Scientific Corporation $165.14 2022-2025 Synergy
Teleflex LLC $148.62 2025 Urolift
Sumitomo Pharma America, INC. $120.16 2025 Gemtesa
Emd Serono, INC. $114.52 2023 Serostim
Abbott Laboratories $102.10 2024-2025 Freestyle Libre 3
Show all 33 companies
CompanyGeneral paymentsYearsTop products
Ardelyx, INC. $82.80 2025 Ibsrela
Phathom Pharmaceuticals, INC. $71.28 2024-2025 Voquezna
Daiichi Sankyo INC. $62.05 2025 Injectafer
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $47.74 2025 Xifaxan
Exact Sciences Corporation $44.54 2024-2025 Cologuard Collection Kit
Astellas Pharma US INC $38.17 2025 Veozah
Azurity Pharmaceuticals, INC. $36.81 2025 Alvesco
Takeda Pharmaceuticals U.S.A., INC. $35.07 2025 Trintellix
Mallinckrodt Hospital Products INC. $26.07 2022
Eisai INC. $21.87 2024
Abbvie INC. $19.47 2024
Seqirus USA INC $19.45 2025 Fluad, Flucelvax
Merck Sharp & Dohme LLC $19.29 2024 Gardasil, Gardasil 9, Capvaxive
Alnylam Pharmaceuticals INC. $18.40 2023 Onpattro
Mannkind Corporation $16.52 2022
Otsuka America Pharmaceutical, INC. $16.38 2024 Rexulti
Aurinia Pharma U.S., INC. $15.66 2022
Dexcom, INC. $15.49 2023 Dexcom G6 Transmitter

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Taryn Haney

$5,130.73

in general payments reported 2019-2025

Years
2022-2025
Top company
Gilead Sciences, INC.
Context
The $3,275 reported for 2025 was more than what 96% of Internal Medicine providers received nationally (typical 2025 total: $156).

https://glasscript.com/doctor/11389491/taryn-haney

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.